Intention to list ProBiotix Health on AQSE | 17-Mar-2022 | 07:00 | RNS |
Exercise of warrants | 09-Mar-2022 | 07:00 | RNS |
Commercial Appointments | 01-Mar-2022 | 07:00 | RNS |
Trading Update | 28-Feb-2022 | 07:00 | RNS |
Commercial and strategy update | 09-Feb-2022 | 07:00 | RNS |
Consumer study of LPLDL in Cholbiome products | 01-Feb-2022 | 07:00 | RNS |
Exercise of Warrants | 27-Jan-2022 | 10:38 | RNS |
Publication of third human study on LPLDL | 18-Jan-2022 | 07:00 | RNS |
Issue of options | 07-Jan-2022 | 07:00 | RNS |
OptiBiotix obtains BRC accreditation | 05-Jan-2022 | 07:00 | RNS |
Exclusive sales and distribution agreement | 15-Dec-2021 | 07:00 | RNS |
Launch of GoFigure range with Apollo Hospitals | 09-Dec-2021 | 07:00 | RNS |
Investor presentation | 01-Dec-2021 | 12:00 | RNS |
Launch of LeanBiome with global nutrition leader | 01-Dec-2021 | 07:00 | RNS |
Formation of OptiBiotix Health India | 17-Nov-2021 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 15.70p |
Change Today | -0.050p |
% Change | -0.32 % |
52 Week High | 39.00 |
52 Week Low | 6.00 |
Volume | 282,744 |
Shares Issued | 97.94m |
Market Cap | £15.38m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
13:21 | 6,042 @ 16.09p |
13:16 | 3,100 @ 16.09p |
13:13 | 2,500 @ 16.09p |
11:43 | 2,000 @ 16.11p |
11:26 | 121 @ 16.47p |
CEO | Stephen O'Hara |
Finance Director | Graham Myers |
You are here: research